IR-Releases

We will keep you informed. Here you will find our (ad-hoc-) releases for investors.

2024

Good interim result for apoBank

28.08.2024 - Deutsche Apotheker- und Ärztebank (apoBank) generated a net profit after tax of €47.8 million.

More
Annual General Meeting 2024

26.04.2024

^{* IR Release is only available in German.}

More
apoBank with strong increase in earnings

11.04.2024 - Deutsche Apotheker- und Ärztebank (apoBank) ended fiscal 2023 with an increase in net profit to €94.2 million (2022: €65.8 million).

More

apoBank increases operating result

30.08.2023 - Deutsche Apotheker- und Ärztebank (apoBank) generated a net profit after tax of €33.0 million in the first half of 2023 (30 June 2022: €32.8 million).

More
Annual General Meeting 2023

28.04.2023

^{* IR Release is only available in German.}

More
Heiko Drews and Dr. Christian Wiermann complete apoBank Management Board

17.04.2023

^{* IR Release is only available in German.}

More
apoBank increases its operating result in 2022

30.03.2023 - Deutsche Apotheker- und Ärztebank (apoBank) closed financial 2022 with a stable net profit of €65.8 million, compared to €65.4 billion in 2021.

More
Alexander Müller leaves apoBank Board of Directors for a new job

12.01.2023

^{* IR Release is only available in German.}

More

apobank adopts Agenda 2025

12.12.2022

^{* IR Release is only available in German.}

More
Holger Wessling leaves apoBank Board of Directors for a new job

15.11.2022

^{* IR Release is only available in German.}

More
Eckhard Lüdering leaves apoBank Board of Directors

30.09.2022

^{* IR Release is only available in German.}

More
Board member Jenny Friese leaves apoBank

13.09.2022

^{* IR Release is only available in German.}

More
apobank appoints two new board members

08.09.2022

^{* IR Release is only available in German.}

More
apoBank reports slightly higher operating result

30.08.2022 - Deutsche Apotheker- und Ärztebank (apoBank) generated a net profit after tax of €32.8 million (30 June 2021: €37.0 million) in the first half of 2022.

More
Annual General Meeting 2022

29.04.2022

^{* IR Release is only available in German.}

More
apoBank reports satisfactory 2021 business performance

07.04.2022 - Deutsche Apotheker- und Ärztebank (apoBank) closed financial 2021 with a stable net profit of €65.4 million, compared to €65.3 million in 2020.

More
Matthias Schellenberg becomes new CEO of apoBank

21.01.2022 - At its meeting on January 21, the Supervisory Board of Deutsche Apotheker- und Ärztebank (apoBank) appointed Matthias Schellenberg (57) as the new CEO.

More

^{* IR Release is only available in German.}

Changes in the management board

10.12.2021 - Ulrich Sommer (59), Chairman of the Management Board is leaving apoBank on December 10th.

More

^{* IR Release is only available in German.}
apoBank posts stable operating income

31.08.2021 - Deutsche Apotheker- und Ärztebank (apoBank) completed the first six months of 2021 with a net profit of €37.0 million (30 June 2020: €32.7 million).

More
Changes in the management board and Annual General Meeting 2021

30.04.2021

^{* IR Release is only available in German.}

More
apoBank reports satisfactory 2020 business performance

15.04.2021 - Deutsche Apotheker- und Ärztebank (apoBank) closed financial 2020 with a stable net profit of €65.3 million compared to €64.1 million in 2019.

More
New board member starts at apobank

04.01.2021 - Jenny Friese has been head of the major customers and markets department since January 1st 2021.

More

^{* IR Release is only available in German.}

New appointments to the sales departments

02.10.2020 - Supervisory board of Deutsche Apotheker- und Ärztebank (apoBank) has newly appointed the board of directors "Private Customers" and "Large Customers and Markets". The press release is only available in German. You find it here.
apoBank reports satisfactory interim result

27.08.2020 - Deutsche Apotheker- und Ärztebank (apoBank) completed the first six month of 2020 with a stable net profit of €32.7 million (30 June 2019: €31.9 million).

More
Annual General Meeting: apoBank members receive a 2 percent dividend

06.05.2020 - The Annual General Meeting took place on Wednesday 6 May 2020. The acompanying press release is available in German only. You will find it here.
apoBank: Respectable result in an environment that remains challenging

01.04.2020 - In fiscal 2019, Deutsche Apotheker- und Ärztebank (apoBank) achieved a stable net profit after tax of €64.1 million (2018: €62.9 million).

More

apoBank continues to expand its customer business

29.08.2019 - Deutsche Apotheker- und Ärztebank (apoBank) generated a stable net profit of €31.9 million (30 June 2018: €31.4 million) in the first six months of 2019.

More
apoBank: Strong base on which to expand business model

08.04.2019 - Deutsche Apotheker- und Ärztebank (apoBank) achieved a stable net profit after tax of €62.9 million (2017: €61.9 million) in fiscal 2018.

More